Of the secondary tests performed, ARID1A rs11247593 was associated with NTDs in whites, and ALDH1A2 rs7169289 was associated with isolated NTDs in African Americans.
This pharmacogenetic substudy of the prospective, double-blind, randomized CIBIS-ELD trial determined the impact of the β1-adrenoceptor Arg189Gly polymorphism on heart-rate responses to bisoprolol or carvedilol in elderly patients with heart failure (421 with sinus rhythm, 107 with atrial fibrillation).
This pharmacogenetic substudy of the prospective, double-blind, randomized CIBIS-ELD trial determined the impact of the β1-adrenoceptor Arg189Gly polymorphism on heart-rate responses to bisoprolol or carvedilol in elderly patients with heart failure (421 with sinus rhythm, 107 with atrial fibrillation).
This pharmacogenetic substudy of the prospective, double-blind, randomized CIBIS-ELD trial determined the impact of the β1-adrenoceptor Arg189Gly polymorphism on heart-rate responses to bisoprolol or carvedilol in elderly patients with heart failure (421 with sinus rhythm, 107 with atrial fibrillation).
Our study revealed significant associations of two variants rs6598860 (OR = 1.27, P = 1.58 × 10<sup>-4</sup>) and rs4589135 (OR = 1.22, P = 3.72 × 10<sup>-4</sup>) in ARID1A with overweight/obesity.
Our study revealed significant associations of two variants rs6598860 (OR = 1.27, P = 1.58 × 10<sup>-4</sup>) and rs4589135 (OR = 1.22, P = 3.72 × 10<sup>-4</sup>) in ARID1A with overweight/obesity.